AU2003246085A1 - Diagnostics/preventives/remedies for respiratory diseases - Google Patents

Diagnostics/preventives/remedies for respiratory diseases

Info

Publication number
AU2003246085A1
AU2003246085A1 AU2003246085A AU2003246085A AU2003246085A1 AU 2003246085 A1 AU2003246085 A1 AU 2003246085A1 AU 2003246085 A AU2003246085 A AU 2003246085A AU 2003246085 A AU2003246085 A AU 2003246085A AU 2003246085 A1 AU2003246085 A1 AU 2003246085A1
Authority
AU
Australia
Prior art keywords
preventives
remedies
diagnostics
respiratory diseases
respiratory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003246085A
Inventor
Hiroki Iwashita
Tatsumi Matsumoto
Shigeru Morita
Atsushi Nakanishi
Masashi Yamasaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2003246085A1 publication Critical patent/AU2003246085A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6884—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from lung
AU2003246085A 2002-06-28 2003-06-27 Diagnostics/preventives/remedies for respiratory diseases Abandoned AU2003246085A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-190732 2002-06-28
JP2002190732 2002-06-28
PCT/JP2003/008167 WO2004002515A1 (en) 2002-06-28 2003-06-27 Diagnostics/preventives/remedies for respiratory diseases

Publications (1)

Publication Number Publication Date
AU2003246085A1 true AU2003246085A1 (en) 2004-01-19

Family

ID=29996898

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003246085A Abandoned AU2003246085A1 (en) 2002-06-28 2003-06-27 Diagnostics/preventives/remedies for respiratory diseases

Country Status (2)

Country Link
AU (1) AU2003246085A1 (en)
WO (1) WO2004002515A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3124045A3 (en) 2006-12-20 2017-05-03 Xoma (Us) Llc Treatment of il-1 beta related diseases
DE102007040395B4 (en) 2007-08-27 2010-03-11 Optotech Optikmaschinen Gmbh Device for the block-free production of single and multi-thickness glasses in the production of prescriptions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001004311A1 (en) * 1999-07-07 2001-01-18 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
JPH1095797A (en) * 1996-09-19 1998-04-14 Terumo Corp Procollagen c-protease enhancer protein
IL134968A0 (en) * 1997-09-17 2001-05-20 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP3695642B2 (en) * 1998-12-01 2005-09-14 ジェネンテック・インコーポレーテッド Promotion or inhibition of angiogenesis and cardiovascularization
WO2001012660A2 (en) * 1999-08-17 2001-02-22 Sagami Chemical Research Center HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS

Also Published As

Publication number Publication date
WO2004002515A1 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
AU2003279338A1 (en) Phenethanolamine derivatives for the treatment of respiratory diseases
AU2003291992A1 (en) Phenylethanolamine derivatives for the treatment of respiratory diseases
HK1081173A1 (en) Phenethanolamine derivative for the treatment of respiratory diseases
AU2003220348A1 (en) Ct integrated respiratory monitor
EP1424078A4 (en) Remedies for respiratory diseases comprising sphingosine-1-phosphate receptor controller
AU2003289330A1 (en) Preventives and/or remedies for central diseases
AU2003272902A1 (en) Remedies
AU2003272962A1 (en) Remedies for allergic diseases
AU2003205898A1 (en) Combination therapy for respiratory disorders
AU2003246085A1 (en) Diagnostics/preventives/remedies for respiratory diseases
AU2003236039A1 (en) Preventives/remedies for hotflash
AU2003252479A1 (en) Remedies for respiratory diseases
AU2003266605A1 (en) Preventives/remedies for neurodegenerative disease
AU2003246088A1 (en) Diagnostics/preventives/re medies for respiratory diseases
AU2003246086A1 (en) Diagnostics/preventives/re medies for respiratory diseases
EP1642589B8 (en) Preventives/remedies for snore or respiratory disturbances during sleep
AU2003227191A1 (en) Remedies for protozoan diseases
AU2003262081A1 (en) Preventives/remedies for neurodegenerative diseases
AU2001271026A1 (en) Remedies for bone diseases
EP1426762A4 (en) Remedies for heart diseases
AU2002311303A1 (en) Preventives/remedies for heart diseases
AU2003242246A1 (en) Remedy for bone mtabolic diseases
AU2003239590A1 (en) Preventives or remedies for immunological diseases
AU2003244191A1 (en) Preventives/remedies for cancer
AU2002304576A1 (en) Hemi-cannula for tracheotomy patients

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase